C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2011
11/24/2011	US20110288235 Process for the Preparation of Pramlintide
11/24/2011	US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
11/24/2011	US20110288035 Pimap39 modulates inflammatory response
11/24/2011	US20110288034 Methods of identifying adipocyte specific genes, the genes identified, and their uses
11/24/2011	US20110288031 Identification of a novel bhd gene
11/24/2011	US20110288030 Paralytic Peptide for Use in Neuromuscular Therapy
11/24/2011	US20110288026 Electroprocessed Collagen and Tissue Engineering
11/24/2011	US20110288024 Compositions and Methods for Treating Arthritis and/or Diseases Involving Cartilage Degeneration
11/24/2011	US20110288023 Cancer drug delivery using modified transferrin
11/24/2011	US20110288019 Methods of increasing platelet and hematopoietic stem cell production
11/24/2011	US20110288011 Peptide therapeutic conjugates and uses thereof
11/24/2011	US20110288009 Leptin and leptin analog conjugates and uses thereof
11/24/2011	US20110288006 Peptides and methods for inducing cell death
11/24/2011	US20110288004 Viral Sequences and Uses Thereof
11/24/2011	US20110288003 Amide based glucagon and superfamily peptide prodrugs
11/24/2011	US20110288002 Novel bag proteins and nucleic acid molecules encoding them
11/24/2011	US20110288001 Biologically active proteins activatable by peptidase
11/24/2011	US20110287955 Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis
11/24/2011	US20110287950 Protein fragment complementation assays for the detection of biological or drug interactions
11/24/2011	US20110287520 Salmonella marker vaccine
11/24/2011	US20110287511 Novel Trichoderma Genes
11/24/2011	US20110287480 Neurogenin
11/24/2011	US20110287478 Protein concentrates and isolates, and processes for the production thereof
11/24/2011	US20110287473 Novel Fluorescent Boron-Substituted Dipyrromethenes and Use Thereof for Diagnosis
11/24/2011	US20110287456 Synthetic peptides, methods and kits for diagnosing autoimmune diseases
11/24/2011	US20110287443 High level expression of recombinant toxin proteins
11/24/2011	US20110287420 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or WNT
11/24/2011	US20110287410 Hepatitis-c virus testing
11/24/2011	US20110287406 Novel HCV core+1 protein, methods for diagnosis of HCV infections, prophylaxis, and for screening of anti-HCV agents
11/24/2011	US20110287256 Pharmaceutical polypeptide dry powder aerosol formulation and method of preparation
11/24/2011	US20110287068 Fibrin and fibrinogen matrices and uses of same
11/24/2011	US20110287047 Cross-beta structures as carrier in vaccines
11/24/2011	US20110287046 Modified streptococcus pneumonia pneumolysin (ply) polypeptides
11/24/2011	US20110287045 Enhanced immune response against infections
11/24/2011	US20110287043 Melanoma antigens and their use in diagnostic and therapeutic methods
11/24/2011	US20110287041 Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification
11/24/2011	US20110287029 Inhibition of the beta3 subunit of l-type ca2+ channels
11/24/2011	US20110287021 Neoplasm specific antibodies and uses thereof
11/24/2011	US20110287016 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
11/24/2011	US20110287013 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof
11/24/2011	US20110287012 Nucleic acid encoding cytokine receptor zcytor17
11/24/2011	US20110287010 Diagnostic methods and markers
11/24/2011	US20110286985 Method of treatment using organotypically cultured skin tissue comprising niks cells that express exogenous hif-1a
11/24/2011	US20110286982 Glucagon analogues
11/24/2011	US20110286981 Glucagon analogues
11/24/2011	US20110286972 Virus growing in hypoxic cell or virus vector expressing gene therein
11/24/2011	US20110286959 Copolymers for suppression of autoimmune diseases, and methods of use
11/24/2011	US20110286958 Hpma polymer platinum chelates
11/24/2011	US20110286936 Targeting vector-phospholipid conjugates
11/24/2011	US20110286934 Membrane transduction peptides, polynucleotides, and methods
11/24/2011	US20110286920 Complex of bifunctional chelating agent and mannosyl human serum albumin
11/24/2011	US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells
11/24/2011	US20110283918 Coatings from natural macromolecules, with gas barrier properties tailored in situ, and related preparation method
11/24/2011	CA2802931A1 Novel glucagon like peptide analogs, composition, and method of use
11/24/2011	CA2801897A1 Marker vaccine for classical swine fever
11/24/2011	CA2799969A1 Degradable clostridial toxins
11/24/2011	CA2799735A1 Biglycan mutants and related therapeutics and methods of use
11/24/2011	CA2799720A1 Methods of crystallising perforin
11/24/2011	CA2799633A1 Improved anti-serum albumin binding variants
11/24/2011	CA2798988A1 Novel dna-binding proteins and uses thereof
11/24/2011	CA2798055A1 Parapoxvirus vectors containing rabies virus antigen
11/23/2011	EP2388325A1 Method for isolating small RNA-molecules using HC-Pro protein
11/23/2011	EP2388271A2 Human Antibodies and Proteins
11/23/2011	EP2388270A2 Modulation of SIRPa - CD47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor
11/23/2011	EP2388269A1 Recombinant der p 2 expressed in pichia pastoris as a "natural-like" allergen for immunotherapy and diagnostic purposes
11/23/2011	EP2388268A1 Recombinant Der p 2 expressed in Pichia pastoris as a "natural-like" allergen for immunotherapy and diagnostic purposes
11/23/2011	EP2388267A1 Alpha-amylase mutants
11/23/2011	EP2388266A2 Fusion molecules and IL-15 variants
11/23/2011	EP2388265A1 Compositions and methods for the treatment of immune related diseases
11/23/2011	EP2388254A1 Bioluminescent protease assay
11/23/2011	EP2388015A1 DNA expression vectors and methods of use
11/23/2011	EP2387716A2 Ets-2 biomarkers for fibrotic diseases and uses thereof
11/23/2011	EP2387588A1 Process for engineering polyvalent, polyspecific fusion proteins using uteroglobin as skeleton and so obtained products
11/23/2011	EP2387582A1 New process for highly selective purification of two plasma proteins: von willebrand factor (vwf) and fibronectin (fn)
11/23/2011	EP2387581A1 Identification of novel antagonist toxins of t-type calcium channel for analgesic purposes
11/23/2011	EP2387579A1 Polypeptides for specific targeting to otx2 target cells
11/23/2011	EP2387412A1 Methods for increasing adiponectin
11/23/2011	EP2084181B1 A method and preparations for the diagnosis and therapy of multiple sclerosis and immune demyelinating polyneuropathy
11/23/2011	EP2076531B1 Telomerase reverse transcriptase fusion protein, nucleotides encoding it, and uses thereof
11/23/2011	EP1991563B1 Peptide sequences and compositions
11/23/2011	EP1979375B1 Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae
11/23/2011	EP1857119B1 Screening for a compound promoting binding between fbl2 and amyloid precursor protein or its c-terminal fragments alpha and beta
11/23/2011	EP1836223B1 Method for identifying a nucleic acid encoding a hemopexin-like structure which specifically binds a predetermined target molecule.
11/23/2011	EP1817411B1 Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
11/23/2011	EP1749026B1 Labelled adrenomedullin derivatives and their use for imaging and therapy
11/23/2011	EP1678305B1 Protozoan strain of the species leishmania infantum of reduced virulence and use thereof
11/23/2011	EP1608683B1 Antibodies directed against hepatitis c virus e1e2 complex and pharmaceutical compositions
11/23/2011	EP1570268B1 CIZ1 Replication protein
11/23/2011	EP1509541B1 Novel recombinant anticoagulant proteins
11/23/2011	EP1507787B1 Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms
11/23/2011	EP1504103B1 Promoters having a modified transcription efficiency and derived from methylotrophic yeast
11/23/2011	EP1297109B1 Hepatitis b virus dna polymerase and surface antigen variants and methods of using same
11/23/2011	EP0932688B1 Chrysosporium cellulase and methods of use
11/23/2011	CN1993467B Gene related with prostate disease and encoding polypeptides and its application
11/23/2011	CN1898563B Method of diagnosing breast cancer
11/23/2011	CN1832960B Immunomodulating compositions, uses therefor and processes for their production
11/23/2011	CN1618801B D-aminoacylase mutants
11/23/2011	CN102257392A A method of protecting against heart failure
11/23/2011	CN102257145A Pesticidal genes from brevibacillus and methods for their use
11/23/2011	CN102257002A Truncated cd20 protein, deltacd20

1 ... 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 ... 2916